Concepedia

Ling-Xian Zhang

LZ

Statistics

Publications

4

Citations

291

H-Index

4

Active since

2022

Affiliations

Second Affiliated Hospital of Nanchang University(Current)

Fudan University

Zhongshan Hospital

Nanchang University

Chinese Academy of Sciences

Ling-Xian Zhang is an author at Second Affiliated Hospital of Nanchang University specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2022–2023

4

Publications

4

The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis

Ling-Xian Zhang, Jian Gao, Xiang Long et al. · Molecular Cancer · 2022 · 166 citations · Full text

, , +17

Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1

Jian Gao, Yong-Qiang Ao, Ling-Xian Zhang et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 77 citations · Full text

, , +17

Elevated circASCC3 limits antitumor immunity by sponging miR-432–5p to upregulate C5a in non-small cell lung cancer

Jian Gao, Ling-Xian Zhang, Yong-Qiang Ao et al. · Cancer Letters · 2022 · 24 citations

, , +16

Tumor-infiltrating CD36+CD8+T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer

Yong-Qiang Ao, Jian Gao, Ling-Xian Zhang et al. · BMC Cancer · 2023 · 24 citations · Full text

, , +17

1–4 of 4